ISSUES

관리자 2023-11-17 72

전북대학교 지역혁신센터와 전주시, KAIST 바이오혁신경영전문대학원이 공동 주최하는 2022 세계 바이오 혁신 포럼(December 2022 World Bio Innovation Forum,이하 WBIF )이 전주에서 열리고 있다.   세계 바이오 헬스의 글로벌 거점 NGO인 WBIF 채수찬 대표는 6일 "이번 포럼은 그간 많은 지역에서 개최된 바이오 헬스 포럼과의 차별화를 위해 미개척 분야인 디지털 치료제, 반려동물 헬스케어와 세계 바이오 헬스 핫이슈인 줄기세포 치료를 주제로 선정했으며 관련 글로벌 전문가와 기업 관계자들의 현장감 있는 주제 발표와 토론을 진행한다"고 밝혔다.   포럼 1일차에는 줄기세포 치료와 장기유사체(Organoids)를...

관리자 2023-03-23 208

Contents (Companion Animal Digital Health Session 5) Felcana & Companion Animal Digital Health Overall Market Trends James Andrews_Chief Executive Officer, FELCANA   Dr. James Andrews talked about Felcana and Trends within the companion animal healthcare space. In 2015, Dr. Andrews set up a pet technology business called Felcana pioneering in telehealth particularly in ...

관리자 2023-03-09 123

Content   (Companion Animal Digital Health Session 5) Electroceutical Approach in Companion Animals' Health Yunhye Kim, CEO, Vrain & Co   Dr. Yunhye Kim gave a talk about the topic of electroceutical approach in companion animals health. Dr. Kim has developed a company for the convenience of animals. She started her presentation with the introduction of Electroc...

관리자 2023-03-09 106

Contents   (Innovations in Companion Animal Medicine Session 3)   Spinal Cord Injury AAV Gene Therapy Using Direct Lineage Reprogramming Technique Junsang Yoo_Chief Executive Officer, Stand Up Therapeutics     Dr. Junsang Yoo presented about gene therapy technology using Stand Up Therapeutics’ efficient direct converter method. The company deal...

관리자 2023-03-09 54

Contents (Innovations in Companion Animal Medicine Session 3) AI-driven Personalized Medicine for Pet Cancer Care Sungwon Lim_Chief Executive Officer, ImpriMed   Dr. Sungwon Lim gave a talk about his company ImpriMed which provides an AI-driven personalized medicine for pet Cancer Care. ImpriMed helps veterinary oncologists find the most effective anti-cancer drugs for indi...

관리자 2023-03-09 35

Contents (Stem Cell Therapy & Organoids Session 2) The Application of Organoid-based Platforms to Personalized Pancreatic Cancer Treatment Jiho Park_Director of Clinical Research Department, NEXT&BIO                              &n...

관리자 2023-01-31 53

Contents   (Stem Cell Therapy & Organoids Session 2) Organoids to Bridge the Gap between Lab and Clinic Robert Vries_Chief Executive Officer,HUB ORGANOIDS   Dr. Robert Vries gave a talk about HUB ORGANOID’s technology working on New Drug development which has led to quite a number of amazing drugs in immune oncology as the last feat of the discovery of try...

관리자 2023-01-31 57

Contents   (Stem Cell Therapy & Organoids Session 1) Adaptable and Hemodynamic Endothelial Cells for Organogenesis and Tumorigenesis Shahin Rafii_Professor, Weill Cornell Medical College   Professor Shahin Rafii gave a talk on what are the challenges for stem cell therapeutic in which some other speakers mentioned the problem which is related to clinical trial w...

관리자 2023-01-31 59

Contents (Stem Cell Therapy & Organoids Session 1) Generation of Hair-Bearing Skin Organoids from Human Pluripotent Stem Cells Jin Kim_Postdoctoral Researcher, Harvard Medical School   Dr. Jin Kim talked about the logic and method for generating hair bearing skin organoid model starting from Human pluripotent stem cells. She briefly discussed other in vitro cell culture...

관리자 2023-01-30 44

Contents (Stem Cell Therapy & Organoid Session 1) Present and Future of Liver Organoid Dongho Choi_Professor, Hanyang University College of Medicine     Professor Dongho Choi gave a talk about present and future liver organoid which is a kind of a specific point of hepatocyte. He started with the information on organoid that had been developed for many years as...

관리자 2023-01-30 44

Contents (Stem Cell Therapy & Organoid Session 1) Development and Considerations for Organoid based Regenerative Medicine Kyung Jin Lee_Chief Technical Officer, ORGANOID SCIENCES   Dr. Kyungjin Lee presented about ORGANOID SCIENCES’ recent data and projects related to organoid-based regenerative medicine. Dr. Lee’s talk was mainly about the company overview...